Celldex Therapeutics, Inc. Increase (Decrease) in Accounts Payable and Accrued Liabilities
Celldex Therapeutics, Inc. (CLDX) reported Increase (Decrease) in Accounts Payable and Accrued Liabilities of $9.85 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities · last filed 2026-08-06
- Celldex Therapeutics, Inc. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2026-06-30 was $10.14M, a 385.95% increase year-over-year.
- Celldex Therapeutics, Inc. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2026-03-31 was -$287.00K.
- Celldex Therapeutics, Inc. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2025-12-31 was $4.60M, a 42.44% decline year-over-year.
- Celldex Therapeutics, Inc. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2025-09-30 was $13.06M, a 94.75% increase year-over-year.
- Celldex Therapeutics, Inc. increase (decrease) in accounts payable and accrued liabilities for fiscal 2025 was $11.03M, a 5.18% decline from fiscal 2024.
- Celldex Therapeutics, Inc. increase (decrease) in accounts payable and accrued liabilities for fiscal 2024 was $11.63M, a 23.98% increase from fiscal 2023.
- Celldex Therapeutics, Inc. increase (decrease) in accounts payable and accrued liabilities for fiscal 2023 was $9.38M, a 200.48% increase from fiscal 2022.
- Celldex Therapeutics, Inc. increase (decrease) in accounts payable and accrued liabilities for fiscal 2022 was $3.12M, a 14.51% decline from fiscal 2021.
| Period end | Increase (Decrease) in Accounts Payable and Accrued Liabilities 3 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 6 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 9 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $10.14M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $9.85M 10-Q · filed 2026-08-06 | $14.45M derived: sum of 3 quarters · filed 2026-08-06 | $27.51M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | -$287.00K 10-Q · filed 2026-05-07 | $4.31M derived: sum of 2 quarters · filed 2026-05-07 | $17.38M derived: sum of 3 quarters · filed 2026-05-07 | $19.46M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $4.60M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $17.66M derived: sum of 2 quarters · filed 2026-02-25 | $19.75M derived: sum of 3 quarters · filed 2026-08-06 | $11.03M 10-K · filed 2026-02-25 |
| 2025-09-30 | $13.06M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $15.15M derived: sum of 2 quarters · filed 2026-08-06 | $6.43M 10-Q · filed 2025-11-10 | $14.42M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $2.09M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$6.63M 10-Q · filed 2026-08-06 | $1.36M derived: sum of 3 quarters · filed 2026-08-06 | $8.07M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | -$8.72M 10-Q · filed 2026-05-07 | -$724.00K derived: sum of 2 quarters · filed 2026-05-07 | $5.98M derived: sum of 3 quarters · filed 2026-05-07 | $7.70M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $7.99M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $14.70M derived: sum of 2 quarters · filed 2026-02-25 | $16.41M derived: sum of 3 quarters · filed 2026-02-25 | $11.63M 10-K · filed 2026-02-25 |
| 2024-09-30 | $6.71M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $8.42M derived: sum of 2 quarters · filed 2025-11-10 | $3.64M 10-Q · filed 2025-11-10 | $7.52M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-06-30 | $1.71M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | -$3.07M 10-Q · filed 2025-08-07 | $810.00K derived: sum of 3 quarters · filed 2026-02-25 | $9.29M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-03-31 | -$4.78M 10-Q · filed 2025-05-08 | -$904.00K derived: sum of 2 quarters · filed 2026-02-25 | $7.57M derived: sum of 3 quarters · filed 2026-02-25 | $8.05M derived: sum of 4 quarters · filed 2026-02-25 |
| 2023-12-31 | $3.88M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $12.35M derived: sum of 2 quarters · filed 2026-02-25 | $12.83M derived: sum of 3 quarters · filed 2026-02-25 | $9.38M 10-K · filed 2026-02-25 |
| 2023-09-30 | $8.48M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $8.96M derived: sum of 2 quarters · filed 2024-11-06 | $5.51M 10-Q · filed 2024-11-06 | $7.91M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | $478.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | -$2.97M 10-Q · filed 2024-08-08 | -$567.00K derived: sum of 3 quarters · filed 2025-02-27 | $1.01M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | -$3.45M 10-Q · filed 2024-05-06 | -$1.04M derived: sum of 2 quarters · filed 2025-02-27 | $537.00K derived: sum of 3 quarters · filed 2025-02-27 | $2.41M derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | $2.40M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $3.98M derived: sum of 2 quarters · filed 2025-02-27 | $5.86M derived: sum of 3 quarters · filed 2025-02-27 | $3.12M 10-K · filed 2025-02-27 |
| 2022-09-30 | $1.58M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $3.46M derived: sum of 2 quarters · filed 2023-11-02 | $720.00K 10-Q · filed 2023-11-02 | $2.62M derived: sum of 4 quarters · filed 2024-02-26 |
| 2022-06-30 | $1.88M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | -$862.00K 10-Q · filed 2023-08-08 | $1.03M derived: sum of 3 quarters · filed 2024-02-26 | $3.54M derived: sum of 4 quarters · filed 2024-02-26 |
| 2022-03-31 | -$2.74M 10-Q · filed 2023-05-04 | -$842.00K derived: sum of 2 quarters · filed 2024-02-26 | $1.67M derived: sum of 3 quarters · filed 2024-02-26 | $2.18M derived: sum of 4 quarters · filed 2024-02-26 |
| 2021-12-31 | $1.90M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-26 | $4.40M derived: sum of 2 quarters · filed 2024-02-26 | $4.92M derived: sum of 3 quarters · filed 2024-02-26 | $3.65M 10-K · filed 2024-02-26 |
| 2021-09-30 | $2.51M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $3.02M derived: sum of 2 quarters · filed 2022-11-09 | $1.76M 10-Q · filed 2022-11-09 | $2.53M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-06-30 | $516.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | -$750.00K 10-Q · filed 2022-08-08 | $24.00K derived: sum of 3 quarters · filed 2023-02-28 | $1.14M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-03-31 | -$1.27M 10-Q · filed 2022-05-05 | -$492.00K derived: sum of 2 quarters · filed 2023-02-28 | $626.00K derived: sum of 3 quarters · filed 2023-02-28 | $1.23M derived: sum of 4 quarters · filed 2023-02-28 |
| 2020-12-31 | $774.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $1.89M derived: sum of 2 quarters · filed 2023-02-28 | $2.49M derived: sum of 3 quarters · filed 2023-02-28 | $1.64M 10-K · filed 2023-02-28 |
| 2020-09-30 | $1.12M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $1.72M derived: sum of 2 quarters · filed 2021-11-09 | $864.00K 10-Q · filed 2021-11-09 | $1.43M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-06-30 | $599.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | -$254.00K 10-Q · filed 2021-08-05 | $309.00K derived: sum of 3 quarters · filed 2022-02-28 | $1.02M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-03-31 | -$853.00K 10-Q · filed 2021-05-06 | -$290.00K derived: sum of 2 quarters · filed 2022-02-28 | $424.00K derived: sum of 3 quarters · filed 2022-02-28 | $281.00K derived: sum of 4 quarters · filed 2022-02-28 |
| 2019-12-31 | $563.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $1.28M derived: sum of 2 quarters · filed 2022-02-28 | $1.13M derived: sum of 3 quarters · filed 2022-02-28 | -$321.00K 10-K · filed 2022-02-28 |
| 2019-09-30 | $714.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $571.00K derived: sum of 2 quarters · filed 2020-11-05 | -$884.00K 10-Q · filed 2020-11-05 | -$4.75M derived: sum of 4 quarters · filed 2021-03-29 |
| 2019-06-30 | -$143.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | -$1.60M 10-Q · filed 2020-08-06 | -$5.46M derived: sum of 3 quarters · filed 2021-03-29 | -$8.81M derived: sum of 4 quarters · filed 2021-03-29 |
| 2019-03-31 | -$1.46M 10-Q · filed 2020-05-06 | -$5.32M derived: sum of 2 quarters · filed 2021-03-29 | -$8.67M derived: sum of 3 quarters · filed 2021-03-29 | -$8.65M derived: sum of 4 quarters · filed 2021-03-29 |
| 2018-12-31 | -$3.86M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-29 | -$7.21M derived: sum of 2 quarters · filed 2021-03-29 | -$7.19M derived: sum of 3 quarters · filed 2021-03-29 | -$13.11M 10-K · filed 2021-03-29 |
| 2018-09-30 | -$3.35M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | -$3.33M derived: sum of 2 quarters · filed 2019-11-12 | -$9.25M 10-Q · filed 2019-11-12 | -$7.10M derived: sum of 4 quarters · filed 2020-03-26 |
| 2018-06-30 | $24.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | -$5.89M 10-Q · filed 2019-08-07 | -$3.75M derived: sum of 3 quarters · filed 2020-03-26 | -$7.83M derived: sum of 4 quarters · filed 2020-03-26 |
| 2018-03-31 | -$5.92M 10-Q · filed 2019-05-07 | -$3.77M derived: sum of 2 quarters · filed 2020-03-26 | -$7.85M derived: sum of 3 quarters · filed 2020-03-26 | -$6.35M derived: sum of 4 quarters · filed 2020-03-26 |
| 2017-12-31 | $2.14M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-26 | -$1.93M derived: sum of 2 quarters · filed 2020-03-26 | -$429.00K derived: sum of 3 quarters · filed 2020-03-26 | -$8.74M 10-K · filed 2020-03-26 |
| 2017-09-30 | -$4.08M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | -$2.57M derived: sum of 2 quarters · filed 2018-11-07 | -$10.89M 10-Q · filed 2018-11-07 | -$4.30M derived: sum of 4 quarters · filed 2019-03-07 |
| 2017-06-30 | $1.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | -$6.81M 10-Q · filed 2018-08-08 | -$222.00K derived: sum of 3 quarters · filed 2019-03-07 | -$1.57M derived: sum of 4 quarters · filed 2019-03-07 |
| 2017-03-31 | -$8.31M 10-Q · filed 2018-05-10 | -$1.73M derived: sum of 2 quarters · filed 2019-03-07 | -$3.07M derived: sum of 3 quarters · filed 2019-03-07 | -$8.33M derived: sum of 4 quarters · filed 2019-03-07 |
| 2016-12-31 | $6.59M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-07 | $5.24M derived: sum of 2 quarters · filed 2019-03-07 | -$13.00K derived: sum of 3 quarters · filed 2019-03-07 | -$4.97M 10-K · filed 2019-03-07 |
| 2016-09-30 | -$1.35M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | -$6.60M derived: sum of 2 quarters · filed 2017-11-07 | -$11.56M 10-Q · filed 2017-11-07 | -$6.62M derived: sum of 4 quarters · filed 2018-03-07 |
| 2016-06-30 | -$5.25M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | -$10.21M 10-Q · filed 2017-08-08 | -$5.27M derived: sum of 3 quarters · filed 2018-03-07 | -$7.86M derived: sum of 4 quarters · filed 2018-03-07 |
| 2016-03-31 | -$4.96M 10-Q · filed 2017-05-09 | -$12.00K derived: sum of 2 quarters · filed 2018-03-07 | -$2.61M derived: sum of 3 quarters · filed 2018-03-07 | $3.14M derived: sum of 4 quarters · filed 2018-03-07 |
| 2015-12-31 | $4.95M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-07 | $2.35M derived: sum of 2 quarters · filed 2018-03-07 | $8.10M derived: sum of 3 quarters · filed 2018-03-07 | $4.88M 10-K · filed 2018-03-07 |
| 2015-09-30 | -$2.59M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-07 | $3.15M derived: sum of 2 quarters · filed 2016-11-07 | -$70.00K 10-Q · filed 2016-11-07 | $2.12M derived: sum of 4 quarters · filed 2017-03-14 |
| 2015-06-30 | $5.74M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08 | $2.52M 10-Q · filed 2016-08-08 | $4.71M derived: sum of 3 quarters · filed 2017-03-14 | $5.01M derived: sum of 4 quarters · filed 2017-03-14 |
| 2015-03-31 | -$3.22M 10-Q · filed 2016-05-05 | -$1.03M derived: sum of 2 quarters · filed 2017-03-14 | -$737.00K derived: sum of 3 quarters · filed 2017-03-14 | -$101.00K derived: sum of 4 quarters · filed 2017-03-14 |
| 2014-12-31 | $2.19M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-14 | $2.48M derived: sum of 2 quarters · filed 2017-03-14 | $3.12M derived: sum of 3 quarters · filed 2017-03-14 | $1.45M 10-K · filed 2017-03-14 |
| 2014-09-30 | $293.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05 | $929.00K derived: sum of 2 quarters · filed 2015-11-05 | -$740.00K 10-Q · filed 2015-11-05 | $3.54M derived: sum of 4 quarters · filed 2016-02-25 |
| 2014-06-30 | $636.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10 | -$1.03M 10-Q · filed 2015-08-10 | $3.25M derived: sum of 3 quarters · filed 2016-02-25 | $6.09M derived: sum of 4 quarters · filed 2016-02-25 |
| 2014-03-31 | -$1.67M 10-Q · filed 2015-04-29 | $2.61M derived: sum of 2 quarters · filed 2016-02-25 | $5.46M derived: sum of 3 quarters · filed 2016-02-25 | $5.36M derived: sum of 4 quarters · filed 2016-02-25 |
| 2013-12-31 | $4.28M derived: 10-K/A 12 month − 10-Q 9 month · filed 2016-02-25 | $7.13M derived: sum of 2 quarters · filed 2016-02-25 | $7.03M derived: sum of 3 quarters · filed 2016-02-25 | $7.24M 10-K/A · filed 2016-02-25 |
| 2013-09-30 | $2.85M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-05 | $2.75M derived: sum of 2 quarters · filed 2014-11-05 | $2.95M 10-Q · filed 2014-11-05 | $5.22M derived: sum of 4 quarters · filed 2015-02-24 |
| 2013-06-30 | -$97.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | $109.00K 10-Q · filed 2014-08-07 | $2.38M derived: sum of 3 quarters · filed 2015-02-24 | $4.86M derived: sum of 4 quarters · filed 2015-02-24 |
| 2013-03-31 | $206.00K 10-Q · filed 2014-05-01 | $2.47M derived: sum of 2 quarters · filed 2015-02-24 | $4.96M derived: sum of 3 quarters · filed 2015-02-24 | $5.02M derived: sum of 4 quarters · filed 2015-02-24 |
| 2012-12-31 | $2.27M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-24 | $4.75M derived: sum of 2 quarters · filed 2015-02-24 | $4.81M derived: sum of 3 quarters · filed 2015-02-24 | $3.76M 10-K · filed 2015-02-24 |
| 2012-09-30 | $2.49M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-08 | $2.54M derived: sum of 2 quarters · filed 2013-11-08 | $1.50M 10-Q · filed 2013-11-08 | $3.02M derived: sum of 4 quarters · filed 2014-03-03 |
| 2012-06-30 | $56.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-06 | -$993.00K 10-Q · filed 2013-08-06 | $527.00K derived: sum of 3 quarters · filed 2014-03-03 | $2.02M derived: sum of 4 quarters · filed 2014-03-03 |
| 2012-03-31 | -$1.05M 10-Q · filed 2013-05-03 | $471.00K derived: sum of 2 quarters · filed 2014-03-03 | $1.96M derived: sum of 3 quarters · filed 2014-03-03 | $1.96M derived: sum of 4 quarters · filed 2014-03-03 |
| 2011-12-31 | $1.52M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-03 | $3.01M derived: sum of 2 quarters · filed 2014-03-03 | $3.00M derived: sum of 3 quarters · filed 2014-03-03 | $2.08M 10-K · filed 2014-03-03 |
| 2011-09-30 | $1.49M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-02 | $1.49M derived: sum of 2 quarters · filed 2012-11-02 | $556.00K 10-Q · filed 2012-11-02 | $1.50M derived: sum of 4 quarters · filed 2013-03-08 |
| 2011-06-30 | -$8.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-09 | -$937.00K 10-Q · filed 2012-08-09 | $11.00K derived: sum of 3 quarters · filed 2013-03-08 | -$277.00K derived: sum of 4 quarters · filed 2013-03-08 |
| 2011-03-31 | -$929.00K 10-Q · filed 2012-05-04 | $19.00K derived: sum of 2 quarters · filed 2013-03-08 | -$269.00K derived: sum of 3 quarters · filed 2013-03-08 | |
| 2010-12-31 | $948.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-08 | $660.00K derived: sum of 2 quarters · filed 2013-03-08 | -$1.19M 10-K · filed 2013-03-08 | |
| 2010-09-30 | -$288.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-03 | -$2.14M 10-Q · filed 2011-11-03 | ||
| 2010-06-30 | -$1.85M 10-Q · filed 2011-08-04 | |||
| 2009-12-31 | -$2.46M 10-K · filed 2012-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |